Penzberg, Germany

Alexander Wrba

This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Wrba. Retrieved from https://idiyas.com/inventor/alexander-wrba-o4jm5h2l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Wrba: Innovator in Erythropoietin Production

Introduction

Alexander Wrba is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of erythropoietin, a crucial hormone for red blood cell production.

Latest Patents

Wrba holds a patent for a process for producing erythropoietin that is free of foreign animal proteins. This innovative method involves expressing DNA coding for erythropoietin in a eukaryotic host cell, which is cultured in a medium devoid of natural mammalian proteins. The erythropoietin produced is then purified through various chromatography techniques, ensuring a high level of purity with minimal contamination from host cell proteins and DNA.

Career Highlights

Alexander Wrba is associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics and biotechnology. His work has been instrumental in advancing the production methods of erythropoietin, which is vital for treating conditions like anemia.

Collaborations

Wrba has collaborated with esteemed colleagues such as Josef Burg and Werner Fürst, contributing to the innovative research and development in his field.

Conclusion

Alexander Wrba's contributions to the production of erythropoietin highlight his role as a key innovator in biotechnology. His patented process not only enhances the purity of erythropoietin but also sets a standard for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…